VALETUDO THERAPEUTICS LLC enters LIMINATUS PHARMA, INC. with 6.17M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 6/16/2025ACC: 0001104659-25-060002
10% Owner
Since Apr 2025
6.17M
Baseline shares
100% direct
6.17M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.0001 per share
DirectShares owned6.17M
Total
6.17M direct6.17M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.0001 per share | 6.17M | Direct |
| Total | 6.17M | 6.17M direct |
Derivative Holdings0
No derivative holdings reported